Skip to main content

Bellevue Group AG

SEC CIK
0001674546
Latest filing
Aug 14, 2026

WVE holding history

Wave Life Sciences, Inc. in every 13F filed by Bellevue Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

WVE overviewAll 13F holders of WVEFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
21
Since Q1 2021
Holdings of WVE by Bellevue Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−5,261−100.0%Sold outHolders
Q1 20265,261$38.1K<0.1%−1,485,257−99.6%ReducedHolders
Q4 20251,490,518$25.3M0.5%−2,603,940−63.6%ReducedHolders
Q3 20254,094,458$30.0M0.6%00.0%UnchangedHolders
Q2 20254,094,458$26.6M0.6%00.0%UnchangedHolders
Q1 20254,094,458$33.1M0.7%00.0%UnchangedHolders
Q4 20244,094,458$50.6M1.0%00.0%UnchangedHolders
Q3 20244,094,458$33.6M0.5%00.0%UnchangedHolders
Q2 20244,094,458$20.4M0.3%00.0%UnchangedHolders
Q1 20244,094,458$25.3M0.4%−400,000−8.9%ReducedHolders
Q4 20234,494,458$22.7M0.3%00.0%UnchangedHolders
Q3 20234,494,458$25.8M0.4%00.0%UnchangedHolders
Q2 20234,494,458$16.4M0.2%00.0%UnchangedHolders
Q1 20234,494,458$19.5M0.3%00.0%UnchangedHolders
Q4 20224,494,458$31.5M0.4%00.0%UnchangedHolders
Q3 20224,494,458$16.2M0.2%00.0%UnchangedHolders
Q2 20224,494,458$14.6M0.2%−68,400−1.5%ReducedHolders
Q1 20224,562,858$9.13M0.1%−40,000−0.9%ReducedHolders
Q4 20214,602,858$14.5M0.1%+2,000,000+76.8%AddedHolders
Q3 20212,602,858$12.8M0.1%00.0%UnchangedHolders
Q2 20212,602,858$17.3M0.2%00.0%UnchangedHolders
Q1 20212,602,858$14.6M0.2%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.